Property:Exclusion criteria
This is a property of type Text.
B
Brown et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial +
Receiving prior treatment for advanced or metastatic disease; taking 2000 IU/d or greater of vitamin D3, had symptomatic genitourinary stones within the past year, or were taking thiazide diuretics. +
Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients +
NI +
Büntzel et al. (2010): Selenium Substitution During Radiotherapy of Solid Tumours - Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients +
NI +
C
Campos et al. (2011): Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy +
Hypothyroidism; depression or other severe psychiatric illness; anemia; previous antineoplastic treatment; contraindications to guarana (insomnia, angina or other cardiovascular disease, uncontrolled hypertension, neurological disease); antidepressant, anxiolytic or sleep-inducing medications +
Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy +
Peyronie’s disease, hormonal abnormalities, any drug consumption that could interact with sildenafil or carnitines as indicated on the technical form, recent (less than 6 months) myocardial or cerebral ischemia or major surgery, alcohol or tobacco abuse, alterations in aspartate and alanine transaminase levels, compensated or uncompensated diabetes, and uncompensated hypertension or hypotension +
Chan et al. (2011): Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer +
No prior or concurrent treatment for prostate cancer; patients with a PSA doubling time <3 months; use of lycopene, fish oil or any other dietary or nutritional supplement within 4 weeks of study entry; use of Finasteride, Dutasteride, Saw Palmetto or any other herbal/nutritional preparation indicated to affect hormone levels within 4 weeks of study entry; use of NSAIDs, COX-2 inhibitors and/or aspirin for more than 7 days over the 1 month prior to study; history of allergic reactions attributed to tomatoes, fish, soybean or olive oil, gelatin capsules, or compounds of similar chemical or biologic composition to lycopene (carotenoids) or fish oil; uncontrolled intercurrent illness including, but not limited to, ongoing infection, congestive heart failure, unstable angina pectoris, cardiac arrhythmia or psychiatric condition that would limit compliance with study requirements +
Chung et al. (2016): Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer +
- Simultaneous malignancies
- Karnofsky performance score <60%
- Previous adverse reactions to the investigational product or salivary scintigraphy
- History of vitamin medication within the past 3 months OR
- Salivary gland excision during surgery +
Cohen et al. (2018): Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial +
NI +
Crew et al. (2012): Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer +
Bilateral breast cancer or metastatic disease; history of gastrointestinal bleeding; uncontrolled or significant comorbid illness; current use of hormone replacement therapy, tamoxifen, or raloxifene +
Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study +
Uncontrolled or severe cardiovascular, pulmonary, or renal disease; current treatment with either chemotherapy or radiation therapy; encephalopathy or psychiatric disorder sufficient to compromise adherence to study methods or data collection; history of stroke, seizure, or primary or metastatic brain tumor; fewer than 60 days of concurrent use of recombinant erythropoietin, and known sensitivity to carnitine +
Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial +
Intake of carnitine, history of seizures, brain metastasis, nausea more than grade 1, and severely compromised renal, liver, or respiratory function +
Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial +
Metastatic disease; history of radiotherapy in the head and neck region; Karnofsky score <60; cognitive impairment; hepatic insufficiency; pregnant or breastfeeding woman; history of hypersensitivity or adverse reactions to marijuana or other cannabinoids; history of schizophrenia or any other form of psychosis +
D
Da Costa et al. (2009): Effectiveness of Guarana (Paullinia cupana) for Postradiation Fatigue and Depression Results of a Pilot Double-Blind Randomized Study +
Patients with a previous history of radiation therapy, anemia, or clinical depression.
Patients who were unable to grant informed consent or those who had medical contraindindications for the use of guarana (because of its psychostimulant effect) such as uncontrolled hypertension) +
Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects +
Previous history of radiation therapy, chemotherapy or surgery; WHO performance index below 70%; uncontrolled systematic diseases +
Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 +
Not treated with external radiotherapy, no other illness except thyroid carcinoma +
Del Giglio (2013): Purified Dry Extract of Paullinia cupana (Guarana) (PC-18) for Chemotherapy-Related Fatigue in Patients with Solid Tumors: An Early Discontinuation Study +
Patients with a history of hypothyroidism, depression, or any other psychiatric disorder, anemia, prior antineoplastic treatment, or the inability to understand and sign an informed consent form.
Patients who could be harmed by the stimulating properties of guarana, such as those with a history of insomnia, angina, or any cardiovascular disease, uncontrolled hypertension, or neurologic disorders. +
Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis +
NI +
Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study +
History of middle or inner ear disease; prior therapy with cisplatin; abnormal audiometric and audiometric impedance tests and abnormal distortion product otoacoustic emissions (DOPOAEs) within the range of frequencies tested +
Dos Santos Martins (2016): Placebo-Controlled, Double-Blind, Randomized Study of a Dry Guarana Extract in Patients with Head and Neck Tumors Undergoing Chemoradiotherapy: Effects on Fatigue and Quality of Life +
Patients with chronic diseases that could induce fatigue, such as chronic renal failure, fibromyalgia, chronic anemia, and untreated hypothyroidism or with problems in the oral mucosa unrelated to the cancer.
Patients with untreated depression and anxiety. +
Dyer et al. (2013): Is reflexology as effective as aromatherapy massage for symptom relief in an adult outpatient oncology population? +
Those already receiving (or who had received in the past two months or who were intending to receive during the period of the study) either aromatherapy massage or reflexology from any practitioner and those unable to receive the intervention due to contraindications or precautions for either therapy. +